IOVS Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-2348 on August 29, 2008
(Investigative Ophthalmology and Visual Science. 2008;49:5458-5465.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.08-2348

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2348v1
49/12/5458    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Copland, D. A.
Right arrow Articles by Dick, A. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Copland, D. A.
Right arrow Articles by Dick, A. D.

The Clinical Time-Course of Experimental Autoimmune Uveoretinitis Using Topical Endoscopic Fundal Imaging with Histologic and Cellular Infiltrate Correlation

David A. Copland,1 Michael S. Wertheim,1,2 W. John Armitage,1 Lindsay B. Nicholson,1,3 Ben J. E. Raveney,*,3,4 and Andrew D. Dick*,1,2,3

1From the Academic Unit of Ophthalmology, Department of Clinical Sciences at South Bristol, and the 3Department of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom; 2Bristol Eye Hospital, Lower Maudlin Street, Bristol, United Kingdom; and the 4Department of Immunology, National Institute of Neuroscience NCNP, Tokyo, Japan.

PURPOSE. EAU is an established preclinical model for assessment of immunotherapeutic efficacy toward translation of therapy for posterior uveitis. Reliable screening of clinical features that correlate with underlying retinal changes and damage has not been possible to date. This study was undertaken to describe, validate, and correlate topical endoscopic fundus imaging (TEFI) with histologic features of murine experimental autoimmune uveoretinitis (EAU), with the intent of generating a rapid noninvasive panretinal assessment of ocular inflammation.

METHODS. EAU was induced in B10.RIII mice by immunization with the peptide RBP-3161-180. The clinical disease course (days 0–63) was monitored and documented using TEFI. Disease severity and pathology were confirmed at various time points by histologic assessment. The composition of the cell infiltrate was also examined and enumerated by flow cytometry.

RESULTS. TEFI demonstrated the hallmark features of EAU, paralleling many of the clinical features of human uveitis, and closely aligned with underlying histologic changes, the severity of which correlated significantly with the number of infiltrating retinal leukocytes. Leukocytic infiltration occurred before manifestation of clinical disease and clinically fulminant disease, as well as cell infiltrate, resolved faster than histologic scores. During the resolution phase, neither the clinical appearance nor number of infiltrating retinal leukocytes returned to predisease levels.

CONCLUSIONS. In EAU, there is a strong correlation between histologic severity and the number of infiltrating leukocytes into the retina. TEFI enhances the monitoring of clinical disease in a rapid and noninvasive fashion. Full assessment of preclinical immunotherapeutic efficacy requires the use of all three parameters: TEFI, histologic assessment, and flow cytometric analysis of retinal infiltrate.





This article has been cited by other articles:


Home page
Arch OphthalmolHome page
B. J. E. Raveney, D. A. Copland, L. B. Nicholson, and A. D. Dick
Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory Disease
Arch Ophthalmol, October 1, 2008; 126(10): 1390 - 1395.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology